Literature DB >> 26143155

Disabled homolog 2 is required for migration and invasion of prostate cancer cells.

Yinyin Xie1, Yuanliang Zhang, Lu Jiang, Mengmeng Zhang, Zhiwei Chen, Dan Liu, Qiuhua Huang.   

Abstract

Disabled homolog 2 (DAB2) is frequently deleted or epigenetically silenced in many human cancer cells. Therefore, DAB2 has always been regarded as a tumor suppressor gene. However, the role of DAB2 in tumor progression and metastasis remains unclear. In this study, DAB2 expression was upregulated along with human prostate cancer (PCa) progression. DAB2 overexpression or knockdown effects in LNCaP and PC3 cell lines were verified to address the biological functions of DAB2 in PCa progression and metastasis. LNCaP and PC3 cell lines were generated from human PCa cells with low and high metastatic potentials, respectively. The results showed that DAB2 shRNA knockdown can inhibit the migratory and invasive abilities of PC3 cells, as well as the tumorigenicity, whereas DAB2 overexpression enhanced LNCaP cell migration and invasion. Further investigation showed that DAB2 regulated the cell migration associated genes in PC3 cells, and the differential DAB2 expression between LNCaP and PC3 cells was partly regulated by histone 4 acetylation. Therefore, DAB2 may play an important role in PCa progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26143155     DOI: 10.1007/s11684-015-0401-3

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  31 in total

1.  Dab2 regulates clathrin assembly and cell spreading.

Authors:  David Chetrit; Naomi Ziv; Marcelo Ehrlich
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

Authors:  A Chao; C-Y Lin; Y-S Lee; C-L Tsai; P-C Wei; S Hsueh; T-I Wu; C-N Tsai; C-J Wang; A-S Chao; T-H Wang; C-H Lai
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

4.  Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.

Authors:  Miki Fuse; Nijiro Nohata; Satoko Kojima; Shinichi Sakamoto; Takeshi Chiyomaru; Kazumori Kawakami; Hideki Enokida; Masayuki Nakagawa; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Int J Oncol       Date:  2011-01-21       Impact factor: 5.650

5.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

6.  The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.

Authors:  B A Hocevar; A Smine; X X Xu; P H Howe
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

7.  Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator.

Authors:  Lianwu Fu; Andras Rab; Li Ping Tang; Steven M Rowe; Zsuzsa Bebok; James F Collawn
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

8.  Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.

Authors:  Z Sheng; W Sun; E Smith; C Cohen; Z Sheng; X X Xu
Journal:  Oncogene       Date:  2000-10-05       Impact factor: 9.867

9.  DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer.

Authors:  S C Mok; W Y Chan; K K Wong; K K Cheung; C C Lau; S W Ng; A Baldini; C V Colitti; C O Rock; R S Berkowitz
Journal:  Oncogene       Date:  1998-05-07       Impact factor: 9.867

10.  Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.

Authors:  Anjali Teckchandani; Natalie Toida; Jake Goodchild; Christine Henderson; Julian Watts; Bernd Wollscheid; Jonathan A Cooper
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

View more
  6 in total

Review 1.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

2.  ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data.

Authors:  You Li; Tayla B Heavican; Neetha N Vellichirammal; Javeed Iqbal; Chittibabu Guda
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

3.  miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis.

Authors:  Chunhui Sun; Xun Yao; Qingyu Jiang; Xiuyong Sun
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

4.  Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2.

Authors:  Kyoungmi Min; Jun Yeob Kim; Suk Kyeong Lee
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

Review 5.  Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.

Authors:  Wensi Tao; Robert Moore; Elizabeth R Smith; Xiang-Xi Xu
Journal:  Front Cell Dev Biol       Date:  2016-11-25

6.  DAB2 suppresses gastric cancer migration by regulating the Wnt/β-catenin and Hippo-YAP signaling pathways.

Authors:  Hua Wang; Surong Dong; Yun Liu; Feng Ma; Jian Fang; Wentao Zhang; Shihe Shao; Hongxing Shen; Jingpeng Jin
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.